Administration of human atrial natriuretic peptide (hANP), a drug for heart failure, for 3 days during the perioperative period inhibited adhesion of the dispersed circulating tumor cells to vascular endothelial cells and suppressed relapses after lung cancer surgery5. The gene discussed is NPPA; the disease is heart failure.